Adma Biologics | ADMA - Current Liabilities

Stock Price
15.72
Daily Change
0.57 3.73%
Monthly
-1.47%
Yearly
-15.83%
Q1 Forecast
14.69

Adma Biologics reported $56.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Adma Biologics USD 56.49M 18.45M Sep/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
BioCryst Pharmaceuticals USD 196.07M 5.83M Dec/2025
Minerva Neurosciences USD 2.29M 381K Dec/2025
Novavax USD 429.87M 40.73M Sep/2025
Omeros USD 85.5M 2.28M Jun/2025
Takeda JPY 2.61T 470.53B Dec/2025